SCHEMBL25607752

SCHEMBL25607752

CC(C)COC(=O)C1=C(CI)[C@H](C)[C@@H]2[C@@H](C(C)O[Si](C)(C)C(C)(C)C)C(=O)N12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FAP Q12884 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22844519 1.00 FAP (0.32) FAP
SCHEMBL22844516 0.90 FAP (0.32) FAP
SCHEMBL25607750 0.90 FAP (0.32) FAP
SCHEMBL22844518 0.89 ELANE (0.32) FAP
SCHEMBL25607748 0.89 ELANE (0.32) FAP
SCHEMBL25601324 0.88 ELANE (0.32) FAP
SCHEMBL22844514 0.85 FAP (0.31) FAP
SCHEMBL25607751 0.85 FAP (0.31) FAP
SCHEMBL22844846 0.84
SCHEMBL23258101 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230173079-A1 Conjugate Molecules DIVERSE BIOTECH, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230173079-A1 Conjugate Molecules CNR2, CNR1, MAG FAP 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.